AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate Cancer
Nouri, Mannan, Varkaris, Andreas, Ridinger, Maya, Dalrymple, Susan L, Dennehy, Christopher M, Isaacs, John T, Einstein, David J, Brennen, W N, Balk, Steven P
Published in Molecular cancer therapeutics (01.10.2024)
Published in Molecular cancer therapeutics (01.10.2024)
Get full text
Journal Article
Targeting Carcinoma-Associated Fibroblasts Within the Tumor Stroma With a Fibroblast Activation Protein-Activated Prodrug
NATHANIEL BRENNEN, W, MARC ROSEN, D, HAO WANG, ISAACS, John T, DENMEADE, Samuel R
Published in JNCI : Journal of the National Cancer Institute (05.09.2012)
Published in JNCI : Journal of the National Cancer Institute (05.09.2012)
Get full text
Journal Article
Thalidomide and Analogues: Current Proposed Mechanisms and Therapeutic Usage
Brennen, W. Nathaniel, Cooper, Carlton R., Capitosti, Scott, Brown, Milton L., Sikes, Robert A.
Published in Clinical prostate cancer (01.06.2004)
Published in Clinical prostate cancer (01.06.2004)
Get full text
Journal Article